Blood test could spare lung cancer patients from useless treatments

NCT ID NCT05889247

Recruiting now Disease control Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated May 17, 2026 · Updated 18 times

Summary

This study looks at whether a blood test (liquid biopsy) can help doctors monitor advanced lung cancer treatment better. 350 patients with non-small cell lung cancer that has spread will be enrolled. The goal is to see if this approach reduces unnecessary treatments and side effects, while also being cost-effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Department of Clinical Oncology
RECRUITING

Hillerød, Region H, Denmark

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Clinical Oncology and Palliative Care
RECRUITING

Næstved, Region Sjælland, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••
Department of Clinical Oncology and Palliative Care
RECRUITING

Roskilde, Region Sjælland, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••
Department of Oncology
NOT_YET_RECRUITING

Aalborg, Denmark

Contact
Department of Oncology
NOT_YET_RECRUITING

Vejle, Denmark

Contact

Contact

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER METASTATIC NON SMALL CELL LUNG CANCER METASTATIC